164 related articles for article (PubMed ID: 26697468)
1. Diagnosis value of CD117 and PDGFRA, alone or in combination DOG1, as biomarkers for gastrointestinal stromal tumors.
Xu C; Han H; Wang J; Zhang B; Shao Y; Zhang L; Wang H; Wang H; Wu Y; Li X; Li R; Tian Y
Ann Transl Med; 2015 Nov; 3(20):308. PubMed ID: 26697468
[TBL] [Abstract][Full Text] [Related]
2. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
3. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
[TBL] [Abstract][Full Text] [Related]
4. Expression of DOG1, PDGFRA, and p16 in Gastrointestinal Stromal Tumors.
Jung SH; Suh KS; Kang DY; Kang DW; Kim YB; Kim ES
Gut Liver; 2011 Jun; 5(2):171-80. PubMed ID: 21814597
[TBL] [Abstract][Full Text] [Related]
5. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
Swalchick W; Shamekh R; Bui MM
Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
[TBL] [Abstract][Full Text] [Related]
6. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status.
West RB; Corless CL; Chen X; Rubin BP; Subramanian S; Montgomery K; Zhu S; Ball CA; Nielsen TO; Patel R; Goldblum JR; Brown PO; Heinrich MC; van de Rijn M
Am J Pathol; 2004 Jul; 165(1):107-13. PubMed ID: 15215166
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Novel Monoclonal Antibody Against DOG1 as a Diagnostic Marker for Gastrointestinal Stromal Tumors.
Abdel-Hadi M; Bessa SS; Hamam SM
J Egypt Natl Canc Inst; 2009 Sep; 21(3):237-47. PubMed ID: 21132034
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
9. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.
Lee CH; Liang CW; Espinosa I
Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677
[TBL] [Abstract][Full Text] [Related]
10. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
11. Histopathological Features of Gastrointestinal Stromal Tumors and the Contribution of DOG1 Expression to the Diagnosis.
Güler B; Özyılmaz F; Tokuç B; Can N; Taştekin E
Balkan Med J; 2015 Oct; 32(4):388-96. PubMed ID: 26740899
[TBL] [Abstract][Full Text] [Related]
12. [To improve the understanding of CD117-negative gastrointestinal stromal tumor].
Zhao Q; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):831-834. PubMed ID: 31550821
[TBL] [Abstract][Full Text] [Related]
13. DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.
Dailey DD; Ehrhart EJ; Duval DL; Bass T; Powers BE
J Vet Diagn Invest; 2015 May; 27(3):268-77. PubMed ID: 25862711
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and immunohistochemical characterization of gastrointestinal stromal tumour at four tertiary health centers in Nigeria using CD117, DOG1, and human epidermal growth factor receptor-2 biomarkers.
Rasheed MW; Abiodun AE; Eziagu UB; Idowu NA; Kabiru A; Adegboye TA; Oluogun WA; Ayoade AA
Ann Afr Med; 2023; 22(4):501-507. PubMed ID: 38358152
[TBL] [Abstract][Full Text] [Related]
15. CLINICOPATHOLOGICAL AND IMMUNO-HISTOCHEMICAL CHARACTERIZATION OF GASTROINTESTINAL STROMAL TUMOUR AT FOUR TERTIARY HEALTH CENTERS IN NIGERIA USING CD117, DOG1, AND HER-2 BIOMARKERS.
Rasheed MW; Afolayan EA; Uchechukwu BE; Najeem AI; Kabiru A; Adegboye AT; Oluogun WA; Adekunle AA
West Afr J Med; 2023 Nov; 40(11 Suppl 1):S25. PubMed ID: 37978874
[TBL] [Abstract][Full Text] [Related]
16. Expression of DOG1 in peripheral blood cells of patients with gastrointestinal stromal tumor.
Feng L; Luo J; Yi F
Arab J Gastroenterol; 2021 Jun; 22(2):99-103. PubMed ID: 34088624
[TBL] [Abstract][Full Text] [Related]
17. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A
Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of biological characteristics and prognosis on gastrointestinal stromal tumor with PDGFRA gene mutation].
Qi C; Pan F; Li J; Li Y; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1280-1284. PubMed ID: 30506540
[TBL] [Abstract][Full Text] [Related]
19. Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View.
Wu CE; Tzen CY; Wang SY; Yeh CN
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31100836
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
